11.06.2014 Views

B O O K - American College of Rheumatology

B O O K - American College of Rheumatology

B O O K - American College of Rheumatology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

• discuss the principles <strong>of</strong> early detection and management <strong>of</strong><br />

infections in patients who develop infections<br />

• determine ways to reduce the risk <strong>of</strong> occurrence <strong>of</strong> infections<br />

in patients with rheumatoid arthritis<br />

B210<br />

Osteoarthritis: Update 2010 (034)<br />

Speaker: Richard F. Loeser, MD; Wake Forest University;<br />

Winston-Salem, NC<br />

Upon completion <strong>of</strong> this session, participants should be able to:<br />

• describe the potential causes and exacerbating factors <strong>of</strong> the<br />

disease<br />

• discuss the appropriate use <strong>of</strong> laboratory testing and imaging<br />

modalities<br />

• design an efficacious, safe and cost-effective therapeutic<br />

strategy<br />

B302<br />

Pediatric <strong>Rheumatology</strong> for Adult Rheumatologists<br />

(035) P f<br />

Speaker: Peter A. Nigrovic, MD; Harvard Medical School; Boston,<br />

MA<br />

Upon completion <strong>of</strong> this session, participants should be able to:<br />

• diagnose the various forms <strong>of</strong> arthritis that are unique to<br />

children<br />

• identify how the evaluation <strong>of</strong> children with rheumatic<br />

diseases may be different from that <strong>of</strong> adults<br />

• describe current treatments <strong>of</strong> arthritis in children<br />

B301<br />

Pediatrics: Dermatomyositis (036) P<br />

Speaker: Adam Huber, MD; IWK Health Centre; Halifax, NS,<br />

Canada<br />

Upon completion <strong>of</strong> this session, participants should be able to:<br />

• discuss recent research developments regarding juvenile<br />

dermatomyositis<br />

• describe the clinical assessment and management <strong>of</strong> juvenile<br />

dermatomyositis<br />

B303<br />

Reactive Arthritis: An Update (037)<br />

Speaker: Atul A. Deodhar, MD; Oregon Health & Science<br />

University; Portland, OR<br />

Upon completion <strong>of</strong> this session, participants should be able to:<br />

• identify various causes <strong>of</strong> reactive arthritis<br />

• discuss mechanisms <strong>of</strong> disease pathogenesis<br />

• describe current treatment options for reactive arthritis<br />

B304<br />

Rheumatoid Arthritis: Biological Agents (038) PS<br />

Speaker: Larry W. Moreland, MD; University <strong>of</strong> Pittsburgh<br />

Medical Center; Pittsburgh, PA<br />

Upon completion <strong>of</strong> this session, participants should be able to:<br />

• identify biologic agents in use for the treatment <strong>of</strong> rheumatoid<br />

arthritis<br />

• describe the risk/benefit pr<strong>of</strong>iles <strong>of</strong> biologic agents<br />

• discuss the emerging biologics and their advantages for the<br />

therapeutic algorithm<br />

B305<br />

Scleroderma: Systemic Sclerosis (039) PM<br />

Speaker: Christopher P. Denton, MD, PhD; Royal Free Hospital;<br />

London, United Kingdom<br />

Upon completion <strong>of</strong> this session, participants should be able to:<br />

• discuss the classification <strong>of</strong> systemic sclerosis and its impact<br />

on treatment and prognosis<br />

• apply cardiopulmonary testing to determine the relative<br />

contributions <strong>of</strong> alveolitis, fibrosis and vasculopathy<br />

• formulate a therapeutic regimen to improve quality <strong>of</strong> life and<br />

organ-specific symptomatology<br />

B306<br />

Vasculitis Mimics (040)<br />

Speaker: Alexandra Villa-Forte, MD, MPH; Cleveland Clinic<br />

Foundation; Cleveland, OH<br />

Upon completion <strong>of</strong> this session, participants should be able to:<br />

• identify clinical settings in which vasculitis should be<br />

suspected<br />

• describe the different medical conditions that could mimic<br />

clinical presentations <strong>of</strong> vasculitis<br />

• identify the challenges in the diagnostic process and how<br />

ancillary test results could be misleading<br />

• discuss the process to distinguish between a vasculitic<br />

syndrome and a “vasculitis mimic”<br />

ACR/ARHP Workshops<br />

7:45 - 9:45 am<br />

Admission to each Workshop requires a separate registration<br />

and ticket. To verify which session you registered for, check<br />

tomake sure the registration code on your ticket matches the<br />

code listed below in parentheses.<br />

B202<br />

Dermatopathology <strong>of</strong> Rheumatic Diseases (216)<br />

Speaker: Lynne Goldberg, MD; Boston University Medical<br />

Center; Boston, MA<br />

Upon completion <strong>of</strong> this session, participants should be able to:<br />

• review dermatopathology in rheumatic diseases<br />

• describe the importance <strong>of</strong> dermatopathology in clinical<br />

decision-making in patients with rheumatic diseases<br />

• apply the knowledge gained to clinical practice<br />

B201<br />

Excel Spreadsheets: Basic Concepts to Elevate Your<br />

Skills Beyond Those <strong>of</strong> Your Children (217)<br />

Speaker: Richard A. Furie, MD; North Shore Long Island Jewish<br />

Health System; Lake Success, NY<br />

Upon completion <strong>of</strong> this session, participants should be able to:<br />

• create a spreadsheet despite having no prior knowledge <strong>of</strong><br />

spreadsheet function or design<br />

• design a graph using spreadsheet date<br />

• distinguish between a database and a spreadsheet<br />

2010 Program Book 57<br />

tuesday

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!